These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16404978)

  • 1. [Optimization of treatment of children with acute intestinal infections by application of Russian biological microbial preparations].
    Feklisova LV
    Vestn Ross Akad Med Nauk; 2005; (12):17-24. PubMed ID: 16404978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics].
    Vorob'ev AA; Bondarenko VM; Lykova EA; Grigor'ev AV; Matsulevich TM
    Vestn Ross Akad Med Nauk; 2004; (2):13-7. PubMed ID: 15101202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Pobedinskaia IN; Gevondian VS; Gevondian NM; Mitrokhin SD; Minaev VI; Dzis NB; Makkaveeva LF; Kovalev IV; Murashova AO; Bondarenko VM
    Antibiot Khimioter; 2000; 45(10):22-7. PubMed ID: 11212396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics.
    Quigley EM
    Gastroenterol Clin North Am; 2007 Sep; 36(3):735-48, xi. PubMed ID: 17950446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impaired interferon status in children with acute respiratory infection and its correction with bifidumbacterin-forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Murashova AO
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):65-7. PubMed ID: 11548264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy of intestinal dysbacteriosis].
    Chekman IS
    Lik Sprava; 2000; (7-8):6-11. PubMed ID: 16786636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment efficacy in acute intestinal infections, chronic diseases of the gastrointestinal tract and viral hepatitis B using large doses of Russian Bifidumbacterin-forte].
    Gracheva NM; Shcherbakov IT; Avakov AA; Matsulevich TV
    Voen Med Zh; 1999 May; 320(5):51-7, 96. PubMed ID: 10401251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric flora in health and disease.
    Guarner F
    Digestion; 2006; 73 Suppl 1():5-12. PubMed ID: 16498248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience of pediatric application of bifidumbacterin multi, a biologically active food supplement].
    Amerkhanova AM; Lavrova AE; Dmitrieva GV; Pyrikova IA; Zubkova ES; Zhilenkova OG; Kuralenko AA
    Vestn Ross Akad Med Nauk; 2005; (12):30-2. PubMed ID: 16404980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acilact and improvement of the health status of sickly children].
    Bliakher MS; Fedorova IM; Lopatina TK; Arkhipov SN; Kapustin IV; Ramazanova ZK; Karpova NV; Ivanov VA; Sharapov NV
    Vestn Ross Akad Med Nauk; 2005; (12):32-5. PubMed ID: 16404981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monkeys as subjects for study of immunobiological preparations].
    Aleshkin VA; Lapin BA; Afanas'ev SS; Pospelova VV; Dzhikidze EK; Afanas'ev MS
    Vestn Ross Akad Med Nauk; 2006; (2):11-5. PubMed ID: 16544898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sources, isolation, characterisation and evaluation of probiotics.
    Fontana L; Bermudez-Brito M; Plaza-Diaz J; Muñoz-Quezada S; Gil A
    Br J Nutr; 2013 Jan; 109 Suppl 2():S35-50. PubMed ID: 23360880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics and prebiotics in preventing episodes of acute otitis media in high-risk children: a randomized, double-blind, placebo-controlled study.
    Cohen R; Martin E; de La Rocque F; Thollot F; Pecquet S; Werner A; Boucherat M; Varon E; Bingen E; Levy C
    Pediatr Infect Dis J; 2013 Aug; 32(8):810-4. PubMed ID: 23429555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biocenosis sparing treatment in the surgery of gastro-intestinal tract].
    Lazarev SM; Voronina OV
    Vestn Khir Im I I Grek; 2009; 168(1):84-8. PubMed ID: 19432155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics.
    Gupta V; Garg R
    Indian J Med Microbiol; 2009; 27(3):202-9. PubMed ID: 19584499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of intestinal dysbacteriosis in children with diabetes mellitus].
    Voronin AA; Taranenko LA; Sidorenko SV
    Antibiot Khimioter; 1999; 44(3):22-4. PubMed ID: 10382034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of loading doses of bifidumbacterin forte for treatment of patients with acute enteric infections].
    Korviakova EP
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):58-61. PubMed ID: 11210639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacterial endotoxinemia in children with intestinal dysbacteriosis].
    Lykova EA; Bondarenko VM; Vorob'ev AA; Sudzhan EV; Minaev VI; Malikov VE
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):67-70. PubMed ID: 10851996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.